FDA Approves Everolimus (Afinitor) for Metastatic Breast Cancer
Cancer Network
The US Food and Drug Administration (FDA) approved the mTOR inhibitor everolimus (Afinitor) last week for use in postmenopausal women with HER2-negative, hormone-receptorā€“positive advanced breast cancer patients. Afinitor was approved in ...
FDA Approves Everolimus for Advanced Breast CancerOncLive
FDA approves Afinitor for Advanced Breast CancerCounsel & Heal
FDA Adds Afinitor to Treatments for Metastatic Breast CancerAbout - News & Issues
Examiner.com -Businessweek -New York Times
all 107 news articles »